Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data
Zoe Kordou(University of Patras), Maria Koromina(Icahn School of Medicine at Mount Sinai), Μαρία Σκώκου(University of Patras), George P. Patrinos(University of Patras), Evangelia Eirini Tsermpini(University of Patras), Wasun Chantratita(Mahidol University), Taisei Mushiroda(RIKEN Center for Integrative Medical Sciences), Koya Fukunaga(RIKEN Center for Integrative Medical Sciences)
Cited by 10
Related Papers
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
|Nature Genetics|2009|523
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity
|Human Genomics|2020|213
Impact of <i>CYP2D6*10</i> on recurrence‐free survival in breast cancer patients receiving adjuvant tamoxifen therapy
|Cancer Science|2008|181
Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
|Journal of Human Genetics|2006|143